Home > Insider Trading > Filing (0001022079-22-000102)

Filing Details

Accession Number:: 0001022079-22-000102
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-05-25 16:31:18
Reporting Period:: 2022-05-23

Accepted Time:: 2022-05-25 16:31:18
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1022079	Quest Diagnostics Inc	DGX	Services-Medical Laboratories (8071)	161387862

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1142624	H Stephen Rusckowski	500 Plaza Drive Secaucus NJ 07094	Chairman, Ceo And President	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2022-05-23	34,898	$103.57	369,731	No	4	M	Direct
Common Stock	Disposition	2022-05-23	33,898	$140.12	335,833	No	4	S	Direct
Common Stock	Disposition	2022-05-23	800	$141.54	335,033	No	4	S	Direct
Common Stock	Disposition	2022-05-23	200	$142.26	334,833	No	4	S	Direct
Common Stock	Acquisiton	2022-05-23	42,568	$86.63	377,401	No	4	M	Direct
Common Stock	Disposition	2022-05-23	41,268	$140.12	336,133	No	4	S	Direct
Common Stock	Disposition	2022-05-23	1,000	$141.51	335,133	No	4	S	Direct
Common Stock	Disposition	2022-05-23	300	$142.24	334,833	No	4	S	Direct
Common Stock	Acquisiton	2022-05-24	126,126	$103.57	460,959	No	4	M	Direct
Common Stock	Disposition	2022-05-24	126,126	$140.12	334,833	No	4	S	Direct
Common Stock	Acquisiton	2022-05-24	156,282	$86.63	491,115	No	4	M	Direct
Common Stock	Disposition	2022-05-24	156,282	$140.12	334,833	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualifed Stock Option (right to buy)	Disposition	2022-05-23	34,898	$103.57	34,898	$103.57
Common Stock	Non-Qualifed Stock Option (right to buy)	Disposition	2022-05-23	42,568	$86.63	42,568	$86.63
Common Stock	Non-Qualifed Stock Option (right to buy)	Disposition	2022-05-24	126,126	$103.57	126,126	$103.57
Common Stock	Non-Qualifed Stock Option (right to buy)	Disposition	2022-05-24	156,282	$86.63	156,282	$86.63

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
136,163	2028-02-19	No	4	M	Direct
171,136	2029-02-18	No	4	M	Direct
10,037	2028-02-19	No	4	M	Direct
14,854	2029-02-18	No	4	M	Direct

Footnotes

This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on April 22, 2022.
This transaction was executed in multiple trades at prices ranging from $140.00 to $140.95. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $141.11 to $141.99. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $142.22 to $142.29. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $140.00 to $140.94. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $141.11 to $141.93. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $142.21 to $142.29. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $140.00 to $140.68. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $140.00 to $140.80. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The options vested in three annual installments beginning with the first on February 19, 2019, the second on February 19, 2020 and the final on February 19, 2021.
The options vested in three annual installments beginning with the first on February 18, 2020, the second on February 18, 2021 and the final on February 18, 2022.